The rise of AI tools like ChatGPT, Gemini, and Perplexity is transforming how patients and healthcare professionals search for health information. Instead of relying on traditional search engines, many now use conversational queries and receive direct answers from AI-generated summaries.
Challenges for pharma marketers
This shift creates both risk and opportunity for pharma marketers. At Fierce Pharma Week in Philadelphia, Will Reese, Chief Innovation Officer at Inizio Evoke, highlighted how “zero-click” searches – where users no longer click through to websites – make it harder for brands to maintain visibility. He also noted the risk of inaccurate AI answers, which could undermine trust if not addressed.
Building credible digital presence
To stay ahead, pharma companies must focus on what Will described as an “aggregate presence” – ensuring that content is credible, accurate, and consistent across all channels. This holistic approach helps improve discoverability while delivering real value to patients and healthcare professionals.
Read the full article in Fierce Pharma to explore Will’s perspective in depth.
Get in touch to learn more about how we’re connecting data, technology, and AI to enable Intelligent Commercialization™ across every stage of the health and life sciences journey.
Jump to a slide with the slide dots.
Explore how Inizio leaders drive Intelligent Commercialization™ by turning data, AI, and expertise into clarity and smarter commercial decisions.
Read moreInsights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.
Read moreWhy Alzheimer’s DMT uptake remains low: Explore key barriers, diagnostic gaps, and market insights from 783 physicians worldwide.
Read more